CVE-2022-2811

Public Exploit
SourceCodester Guest Management System myform.php cross site scripting

Description

A vulnerability classified as problematic has been found in SourceCodester Guest Management System. This affects an unknown part of the file myform.php. The manipulation of the argument name leads to cross site scripting. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-206397 was assigned to this vulnerability.

Category

3.5
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.08%
Third-Party Advisory ax1x.com Third-Party Advisory vuldb.com
Affected: SourceCodester Guest Management System
Published at:
Updated at:

References

Link Tags
https://s1.ax1x.com/2022/08/13/vtDEFO.png third party advisory exploit
https://vuldb.com/?id.206397 permissions required vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2022-2811?
CVE-2022-2811 has been scored as a low severity vulnerability.
How to fix CVE-2022-2811?
To fix CVE-2022-2811, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-2811 being actively exploited in the wild?
It is possible that CVE-2022-2811 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-2811?
CVE-2022-2811 affects SourceCodester Guest Management System.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.